Search

Kevin M. Johnson

Examiner (ID: 17187)

Most Active Art Unit
1793
Art Unit(s)
1793, 1732
Total Applications
255
Issued Applications
85
Pending Applications
85
Abandoned Applications
85

Applications

Application numberTitle of the applicationFiling DateStatus
Array ( [id] => 17226999 [patent_doc_number] => 20210353555 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-11-18 [patent_title] => NANOPARTICLES BASED ON OPTIONALLY ALKOXYLATED POLY(ALKYL CYANOACRYLATES) HAVING A DEFINED DEGREE OF POLYMERIZATION [patent_app_type] => utility [patent_app_number] => 17/339138 [patent_app_country] => US [patent_app_date] => 2021-06-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 19613 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -17 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17339138 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/339138
NANOPARTICLES BASED ON OPTIONALLY ALKOXYLATED POLY(ALKYL CYANOACRYLATES) HAVING A DEFINED DEGREE OF POLYMERIZATION Jun 3, 2021 Abandoned
Array ( [id] => 18495999 [patent_doc_number] => 20230218525 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-07-13 [patent_title] => Solid Self-Nanoemulsifying Drug Delivery System (S-SNEDDS) [patent_app_type] => utility [patent_app_number] => 17/999920 [patent_app_country] => US [patent_app_date] => 2021-05-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 11139 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -14 [patent_words_short_claim] => 57 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17999920 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/999920
Solid Self-Nanoemulsifying Drug Delivery System (S-SNEDDS) May 25, 2021 Abandoned
Array ( [id] => 20534383 [patent_doc_number] => 12551434 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2026-02-17 [patent_title] => Zwitterionic polymer particle compositions and related methods [patent_app_type] => utility [patent_app_number] => 17/925234 [patent_app_country] => US [patent_app_date] => 2021-05-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 33 [patent_figures_cnt] => 48 [patent_no_of_words] => 27514 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 142 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17925234 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/925234
Zwitterionic polymer particle compositions and related methods May 19, 2021 Issued
Array ( [id] => 20592343 [patent_doc_number] => 12576039 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2026-03-17 [patent_title] => Lipid-polymer compositions and methods of use [patent_app_type] => utility [patent_app_number] => 17/323052 [patent_app_country] => US [patent_app_date] => 2021-05-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 25 [patent_figures_cnt] => 25 [patent_no_of_words] => 15014 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 106 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17323052 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/323052
Lipid-polymer compositions and methods of use May 17, 2021 Issued
Array ( [id] => 17242007 [patent_doc_number] => 20210361750 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-11-25 [patent_title] => Anti-Viral Lactoferrin Facemask [patent_app_type] => utility [patent_app_number] => 17/322815 [patent_app_country] => US [patent_app_date] => 2021-05-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6404 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -17 [patent_words_short_claim] => 25 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17322815 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/322815
Anti-Viral Lactoferrin Facemask May 16, 2021 Abandoned
Array ( [id] => 17272760 [patent_doc_number] => 20210378958 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-12-09 [patent_title] => Emulsions and extended release formulations including cannabis-derived compounds and related methods [patent_app_type] => utility [patent_app_number] => 17/300337 [patent_app_country] => US [patent_app_date] => 2021-05-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 1102 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => 0 [patent_words_short_claim] => 37 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17300337 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/300337
Emulsions and extended release formulations including cannabis-derived compounds and related methods May 13, 2021 Abandoned
Array ( [id] => 17312741 [patent_doc_number] => 20210401789 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-12-30 [patent_title] => OPHTHALMIC COMPOSITIONS AND METHODS FOR TREATING EYES [patent_app_type] => utility [patent_app_number] => 17/317078 [patent_app_country] => US [patent_app_date] => 2021-05-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 11399 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -11 [patent_words_short_claim] => 38 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17317078 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/317078
OPHTHALMIC COMPOSITIONS AND METHODS FOR TREATING EYES May 10, 2021 Abandoned
Array ( [id] => 17480478 [patent_doc_number] => 20220087982 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-03-24 [patent_title] => PHARMACEUTICAL COMPOSITION [patent_app_type] => utility [patent_app_number] => 17/313312 [patent_app_country] => US [patent_app_date] => 2021-05-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 9855 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -11 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17313312 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/313312
Pharmaceutical composition May 5, 2021 Issued
Array ( [id] => 18672839 [patent_doc_number] => 20230310284 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-10-05 [patent_title] => DISSOLVABLE HYDROGEN PEROXIDE TEETH WHITENING STRIP OR FILM [patent_app_type] => utility [patent_app_number] => 17/922864 [patent_app_country] => US [patent_app_date] => 2021-05-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 15210 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -18 [patent_words_short_claim] => 57 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17922864 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/922864
DISSOLVABLE HYDROGEN PEROXIDE TEETH WHITENING STRIP OR FILM May 4, 2021 Pending
Array ( [id] => 17168656 [patent_doc_number] => 20210322326 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-10-21 [patent_title] => HYDROGEL PARTICLE CARRIERS FOR DELIVERY OF THERAPEUTIC/DIAGNOSTIC AGENTS [patent_app_type] => utility [patent_app_number] => 17/232336 [patent_app_country] => US [patent_app_date] => 2021-04-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5487 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -21 [patent_words_short_claim] => 62 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17232336 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/232336
HYDROGEL PARTICLE CARRIERS FOR DELIVERY OF THERAPEUTIC/DIAGNOSTIC AGENTS Apr 15, 2021 Abandoned
Array ( [id] => 17050667 [patent_doc_number] => 20210260101 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-08-26 [patent_title] => POTENTIATED ANTIBIOTIC COMPOSITIONS AND METHODS OF USE FOR TREATING BACTERIAL INFECTIONS AND BIOFILMS [patent_app_type] => utility [patent_app_number] => 17/231854 [patent_app_country] => US [patent_app_date] => 2021-04-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 32491 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -17 [patent_words_short_claim] => 30 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17231854 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/231854
POTENTIATED ANTIBIOTIC COMPOSITIONS AND METHODS OF USE FOR TREATING BACTERIAL INFECTIONS AND BIOFILMS Apr 14, 2021 Abandoned
Array ( [id] => 17154758 [patent_doc_number] => 20210315809 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-10-14 [patent_title] => ORAL CARE COMPOSITIONS AND METHODS [patent_app_type] => utility [patent_app_number] => 17/227978 [patent_app_country] => US [patent_app_date] => 2021-04-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 12347 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -47 [patent_words_short_claim] => 22 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17227978 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/227978
ORAL CARE COMPOSITIONS AND METHODS Apr 11, 2021 Abandoned
Array ( [id] => 16977563 [patent_doc_number] => 20210221800 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-07-22 [patent_title] => CRYSTALLINE COMPOUNDS AND METHODS OF MAKING THE SAME [patent_app_type] => utility [patent_app_number] => 17/220245 [patent_app_country] => US [patent_app_date] => 2021-04-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 50753 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -27 [patent_words_short_claim] => 33 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17220245 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/220245
CRYSTALLINE COMPOUNDS AND METHODS OF MAKING THE SAME Mar 31, 2021 Abandoned
Array ( [id] => 17472144 [patent_doc_number] => 20220079648 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-03-17 [patent_title] => METHODS OF ALLEVIATING SYMPTOMS OF OCULAR SURFACE DISCOMFORT USING MEDICAL ICE SLURRY [patent_app_type] => utility [patent_app_number] => 17/439749 [patent_app_country] => US [patent_app_date] => 2021-03-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 9593 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -26 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17439749 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/439749
Methods of alleviating symptoms of ocular surface discomfort using medical ice slurry Mar 25, 2021 Issued
Array ( [id] => 18374246 [patent_doc_number] => 20230149323 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-05-18 [patent_title] => INHIBITORS OF THE INTERACTION OF THE UPAR/FPRS RECEPTORS [patent_app_type] => utility [patent_app_number] => 17/916285 [patent_app_country] => US [patent_app_date] => 2021-03-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4971 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -31 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17916285 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/916285
INHIBITORS OF THE INTERACTION OF THE UPAR/FPRS RECEPTORS Mar 22, 2021 Pending
Array ( [id] => 17212975 [patent_doc_number] => 20210346311 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-11-11 [patent_title] => Base Composition for Tape Agent [patent_app_type] => utility [patent_app_number] => 17/206781 [patent_app_country] => US [patent_app_date] => 2021-03-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 14076 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -11 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17206781 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/206781
Base Composition for Tape Agent Mar 18, 2021 Abandoned
Array ( [id] => 18690882 [patent_doc_number] => 20230321044 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-10-12 [patent_title] => TREATMENT OR PREVENTION METHOD FOR CHRONIC HEART FAILURE [patent_app_type] => utility [patent_app_number] => 17/796606 [patent_app_country] => US [patent_app_date] => 2021-03-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 8185 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -10 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17796606 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/796606
TREATMENT OR PREVENTION METHOD FOR CHRONIC HEART FAILURE Mar 17, 2021 Pending
Array ( [id] => 17095383 [patent_doc_number] => 20210283174 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-09-16 [patent_title] => OXYGENATED EMULSION FOR TREATMENT OF OCULAR INJURY [patent_app_type] => utility [patent_app_number] => 17/200253 [patent_app_country] => US [patent_app_date] => 2021-03-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 9564 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -15 [patent_words_short_claim] => 87 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17200253 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/200253
OXYGENATED EMULSION FOR TREATMENT OF OCULAR INJURY Mar 11, 2021 Pending
Array ( [id] => 18558148 [patent_doc_number] => 11723366 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2023-08-15 [patent_title] => Alkali metal salt for use in treatment of [patent_app_type] => utility [patent_app_number] => 17/199917 [patent_app_country] => US [patent_app_date] => 2021-03-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 8 [patent_no_of_words] => 8484 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 80 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17199917 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/199917
Alkali metal salt for use in treatment of Mar 11, 2021 Issued
Array ( [id] => 16913963 [patent_doc_number] => 20210187055 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-06-24 [patent_title] => LISINOPRIL FORMULATIONS [patent_app_type] => utility [patent_app_number] => 17/194021 [patent_app_country] => US [patent_app_date] => 2021-03-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 19117 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -18 [patent_words_short_claim] => 73 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17194021 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/194021
Lisinopril formulations Mar 4, 2021 Issued
Menu